Present and future projects of the international breast cancer study group
✍ Scribed by Aron Goldhirsch; Richard D. Gelber; Monica Castiglione; Karen N. Price; Carl-Magnus Rudenstam; Jurij Lindtner; John Collins; Hans-Jörg Senn; Kurt W. Brunner; Enzo Galligioni; Franco Cavalli; Anne Gudgeon; Hernan Cortes-Funes; Martin Tattersall; Giovanni Marini; Michael Byrne; Ray Snyder; John F. Forbes; Christoph Hürny; Alan Coates
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 933 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of timing of chemotherapy with respect to tumor surgery and late introduction of chemotherapy were also evaluated. Ongoing and future trials continue in this tradition to investigate combinations of available endocrine therapies and cytotoxic agents. Cancer 1994; 74:1139-49.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Although many patients take antioxidant dietary supplements during breast cancer treatment, the benefits of such supplementation are unproven. The authors of this report analyzed the prevalence of and factors associated with antioxidant supplement use during breast cance
Breast cancer is hormonally mediated and oestrogens are the prime agents in tumour expression. This was the main conclusion of the meeting in June, 1980, of the Multidisciplinary Project on Breast Cancer of the International Union Against Cancer (Miller and Bulbrook, 1980). The present report conce